Redefining Polycystic Ovary Syndrome As Polyendocrine Metabolic Ovarian Syndrome: Implications For Diagnosis, Pathophysiology And Clinical Management
January 2026
in “
International Journal of Gynaecology Sciences
”
Studysummary This review discusses the proposal to rename Polycystic Ovary Syndrome as PolyMetabolic Ovarian Syndrome and reports no new clinical results, highlighting diagnostic misconceptions and the importance of personalized management.
Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
Read the full study on gynaecologyjournal.net →